HomeCompareIBXNF vs O

IBXNF vs O: Dividend Comparison 2026

IBXNF yields 200.00% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBXNF wins by $119.33M in total portfolio value
10 years
IBXNF
IBXNF
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full IBXNF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — IBXNF vs O

📍 IBXNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBXNFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBXNF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBXNF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXNF
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, IBXNF beats the other by $51,145,348.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXNF + O for your $10,000?

IBXNF: 50%O: 50%
100% O50/50100% IBXNF
Portfolio after 10yr
$59.70M
Annual income
$30,090,597.24/yr
Blended yield
50.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

IBXNF
No analyst data
Altman Z
5.4
Piotroski
6/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXNF buys
0
O buys
0
No recent congressional trades found for IBXNF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBXNFO
Forward yield200.00%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$119.36M$34.2K
Annual income after 10y$60,176,096.29$5,098.20
Total dividends collected$112.49M$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: IBXNF vs O ($10,000, DRIP)

YearIBXNF PortfolioIBXNF Income/yrO PortfolioO Income/yrGap
1← crossover$30,700$20,000.00$10,818$607.86+$19.9KIBXNF
2$90,232$57,383.18$11,786$741.30+$78.4KIBXNF
3$254,173$157,624.56$12,944$910.50+$241.2KIBXNF
4$686,927$414,961.74$14,343$1,127.28+$672.6KIBXNF
5$1,783,118$1,048,106.39$16,053$1,408.17+$1.77MIBXNF
6$4,450,613$2,542,677.12$18,167$1,776.65+$4.43MIBXNF
7$10,693,420$5,931,263.38$20,815$2,266.60+$10.67MIBXNF
8$24,760,608$13,318,648.86$24,179$2,927.66+$24.74MIBXNF
9$55,315,649$28,821,798.66$28,521$3,833.95+$55.29MIBXNF
10$119,363,841$60,176,096.29$34,218$5,098.20+$119.33MIBXNF

IBXNF vs O: Complete Analysis 2026

IBXNFStock

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Full IBXNF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this IBXNF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXNF vs SCHDIBXNF vs JEPIIBXNF vs KOIBXNF vs MAINIBXNF vs STAGIBXNF vs ADCIBXNF vs NNNIBXNF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.